Pharmacokinetics of acyclovir in the cat.
Owens
J G
JG
Pfizer Inc., Central Research Division, Groton, CT 06340, USA.
Nasisse
M P
MP
Tadepalli
S M
SM
Dorman
D C
DC
D000212:Acyclovir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics*; D000284:Administration, Oral; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D001682:Biological Availability; D002415:Cats; D002851:Chromatography, High Pressure Liquid / Q000662:veterinary; D005260:Female; D006207:Half-Life; D007408:Intestinal Absorption; D011355:Prodrugs / Q000493:pharmacokinetics; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics
D000998:Antiviral Agents; D011355:Prodrugs; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir